MarginsXMarginsX
Home › Markets › Health Care › NMAD

Nomad Power Solutions Inc. (NMAD)

NMAD trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$2.80
+19.15% on the day
Market cap
$45.1M
Nano cap
Revenue
No annual revenue filed since the period ending 2015-12-31
Net income
No annual revenue filed since the period ending 2015-12-31

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026.

Profile

FieldValue
TickerNMAD on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO yearNot reported by the screener
SEC CIK0001335105
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

No annual revenue filed since the period ending 2015-12-31.

Warning signs

Cash runway
27.9 months
$12.7M cash at June 30, 2026
Share count, 1 year
+253.0%
2025-08-05 to 2026-08-10 · +615.8% over 3 years
Going-concern doubt
Yes
10-Q filed August 14, 2026
Insider net buying, 12 months
$0
Through September 30, 2026
SignFindingSource
Going concernStates substantial doubt about continuing as a going concern.
"As a result of the foregoing, management has concluded that there is substantial doubt regarding the Company's ability to continue as a going concern for a period of at least 12 months beyond the date these condensed consolidated financial statements are issued."
10-Q 2026-08-14
Cash and burn$12.7M cash; operating cash flow -$1.4M a quarter.Report 2026-06-30
Shares outstanding16,101,068 (2026-08-10); 4,561,363 a year earlier; 2,249,290 three years earlier.Cover page 2026-08-10
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 2 424B5 takedowns, 2 at the marketLatest 2026-06-04
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
Delisting25-NSE/A filed25-NSE/A 2025-11-28
AuditorWeinberg & Company, P.A., Los Angeles, California, United StatesPCAOB Form AP 2026-04-03
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $0, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q2 2026
2026-06-30
Not filed-$2.3M-$1.6M$12.7MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q1 2026
2026-03-31
Not filed-$2.0M-$1.8M$3.3MNo debt tagsNeeds four quarters10-Q 2026-08-14
Q4 2025
2025-12-31
Not filed-$2.6M-$1.1M$5.1MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2025
2025-09-30
Not filed-$2.0M-$927K$2.9MNo debt tagsNeeds four quarters10-Q 2025-11-12
Q2 2025
2025-06-30
Not filed-$776K-$487K$887KNo debt tagsNeeds four quarters10-Q 2025-08-07
Q1 2025
2025-03-31
Not filed-$710K-$568K$1.4MNo debt tagsNeeds four quarters10-Q 2025-05-12
Q4 2024
2024-12-31
Not filed-$618K-$599K$1.0MNo debt tagsNeeds four quarters10-K 2026-03-31
Q3 2024
2024-09-30
Not filed-$986K-$958K$1.6MNo debt tagsNeeds four quarters10-Q 2025-11-12

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B52026-06-04
Latest annual report10-K2026-03-31
Latest quarterly / interim10-Q2026-11-16
Latest current report8-K2026-11-16
Latest proxyDEF 14A2026-07-27

Source: SEC EDGAR submissions feed, 534 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-34.7%
1 month-45.1%
3 months-42.0%
Year to date-40.2%
1 year-45.3%
From 52-week high-70.8%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
TLPHTalphera Inc.$0.8609-4.98%$44.7M
MISTMilestone Pharmaceuticals Inc. Common Shares$0.3650-29.81%$45.4M
HYFTMindWalk Holdings Corp.$0.9378-8.95%$44.6M
ONCYOncolytics Biotech Inc.$0.3399-8.14%$44.6M
RNXTRenovoRx Inc.$0.9549-8.18%$46.1M
ANVSAnnovis Bio Inc.$0.7500-19.02%$46.5M
ATNMActinium Pharmaceuticals Inc. (Delaware)$1.49-9.15%$46.8M
PLRXPliant Therapeutics Inc.$0.6932-0.55%$43.0M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier